Skip to main content
Erschienen in: Digestive Diseases and Sciences 12/2016

22.09.2016 | Original Article

Age and Prevalence of Esophageal Reflux Disease in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study

verfasst von: Yoshio Ikeda, Shinya Furukawa, Takenori Sakai, Tetsuji Niiya, Hiroaki Miyaoka, Teruki Miyake, Shin Yamamoto, Hidenori Senba, Yasunori Yamamoto, Eiji Arimitsu, Sen Yagi, Hiroki Utsunomiya, Keiko Tanaka, Eiji Takeshita, Bunzo Matsuura, Yoshihiro Miyake, Yoichi Hiasa

Erschienen in: Digestive Diseases and Sciences | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Only limited epidemiological evidence exists regarding the relationship between age and gastroesophageal reflux disease (GERD) among Japanese patients with type 2 diabetes mellitus.

Aim

The purpose of the present study is to investigate this issue among Japanese patients with type 2 diabetes mellitus.

Methods

A multicenter cross-sectional study was conducted in 847 Japanese patients with type 2 diabetes mellitus. Subjects were divided into quartiles according to age: (1) 19 ≤ age < 56, (2) 56 ≤ age < 64, (3) 64 ≤ age < 71, and (4) 71 ≤ age < 89. GERD was defined as present when a subject had a Carlsson–Dent self-administered questionnaire (QUEST) score ≥4.

Results

The prevalence of GERD was 31.5 %. Younger age was independently associated with a higher prevalence of GERD: the adjusted odds ratios (95 % confidence intervals) for GERD in relation to age < 56, 56 ≤ age < 64, 64 ≤ age < 71, and ≥71 were 3.73 (2.16–6.53), 1.98 (1.21–3.27), 1.66 (1.05–2.68), and 1.00 (reference), respectively (P for trend = 0.001). Among 201 patients with PPI or histamine H2-receptor antagonist (H2RA), less than 56 years of age was independently positively associated with GERD: the adjusted OR was 5.68 (95 % CI 1.55–22.18) (P for trend = 0.02).

Conclusions

Younger age may be independently positively associated with GERD among Japanese type 2 diabetes mellitus patients, regardless of the use of PPI or H2RA.
Literatur
1.
Zurück zum Zitat Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15000 adults. Arch Intern Med. 2001;161:1989–1996.CrossRefPubMed Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15000 adults. Arch Intern Med. 2001;161:1989–1996.CrossRefPubMed
2.
Zurück zum Zitat Farup C, Kleinman L, Sholam S, et al. The impact of nocturnal symptoms associated with gastoesophageal reflux disease on health-related quality of life. Arch Intern Med. 2001;161:45–52.CrossRefPubMed Farup C, Kleinman L, Sholam S, et al. The impact of nocturnal symptoms associated with gastoesophageal reflux disease on health-related quality of life. Arch Intern Med. 2001;161:45–52.CrossRefPubMed
3.
Zurück zum Zitat Talley NJ, Young L, Bytzer P, et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastorenterol. 2001;96:71–76.CrossRef Talley NJ, Young L, Bytzer P, et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastorenterol. 2001;96:71–76.CrossRef
4.
Zurück zum Zitat Sun XM, Tan JC, Zhu Y, Lin L. Association between diabetes mellitus and gastroesophageal reflux disease: a meta-analysis. World J Gastroenterol. 2015;21:3085–3092.CrossRefPubMedPubMedCentral Sun XM, Tan JC, Zhu Y, Lin L. Association between diabetes mellitus and gastroesophageal reflux disease: a meta-analysis. World J Gastroenterol. 2015;21:3085–3092.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Horikawa A, Ishii-Nozawa R, Ohguro M, et al. Prevalence of GORD (gastro-oesophageal reflux disease) in Type 2 diabetes and a comparison of clinical profiles between diabetic patients with and without GORD. Diabet Med. 2009;26:228–233.CrossRefPubMed Horikawa A, Ishii-Nozawa R, Ohguro M, et al. Prevalence of GORD (gastro-oesophageal reflux disease) in Type 2 diabetes and a comparison of clinical profiles between diabetic patients with and without GORD. Diabet Med. 2009;26:228–233.CrossRefPubMed
6.
Zurück zum Zitat Sun H, Yi L, Wu P, Li Y, Luo B, Xu S. Prevalence of gastroesophageal reflux disease in type 2 diabetes mellitus. Gastroenterol Res Pract 2014; Article ID 601571, 4. Sun H, Yi L, Wu P, Li Y, Luo B, Xu S. Prevalence of gastroesophageal reflux disease in type 2 diabetes mellitus. Gastroenterol Res Pract 2014; Article ID 601571, 4.
7.
Zurück zum Zitat Nishida T, Tsuji S, Tsujii M, et al. Gastroesophageal reflux disease related to diabetes: analysis of 241 cases with type 2 diabetes mellitus. J Gastroenterol Hepatol. 2004;19:258–265.CrossRefPubMed Nishida T, Tsuji S, Tsujii M, et al. Gastroesophageal reflux disease related to diabetes: analysis of 241 cases with type 2 diabetes mellitus. J Gastroenterol Hepatol. 2004;19:258–265.CrossRefPubMed
8.
Zurück zum Zitat Kase H, Hattori Y, Sato N, Banba N, Kasai K. Symptoms of gastroesophageal reflux in diabetes patients. Diabetes Res Clin Pract. 2008;79:e6–e7.CrossRefPubMed Kase H, Hattori Y, Sato N, Banba N, Kasai K. Symptoms of gastroesophageal reflux in diabetes patients. Diabetes Res Clin Pract. 2008;79:e6–e7.CrossRefPubMed
9.
Zurück zum Zitat Haneda M, Utsunomiya K, Koya D, et al. A new classification of diabetic nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy. J Diabetes Investig. 2015;6:242–246.CrossRefPubMedPubMedCentral Haneda M, Utsunomiya K, Koya D, et al. A new classification of diabetic nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy. J Diabetes Investig. 2015;6:242–246.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Yasuda H, Sanada M, Kitada K, et al. Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. Diabetes Res Clin Pract. 2007;77:S178–S183.CrossRefPubMed Yasuda H, Sanada M, Kitada K, et al. Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. Diabetes Res Clin Pract. 2007;77:S178–S183.CrossRefPubMed
11.
Zurück zum Zitat Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–1029.CrossRefPubMed Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–1029.CrossRefPubMed
12.
Zurück zum Zitat Du J, Liu J, Zhang H, Yu CH, Li YM. Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination. World J Gastroenterol. 2007;13:6009.CrossRefPubMedPubMedCentral Du J, Liu J, Zhang H, Yu CH, Li YM. Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination. World J Gastroenterol. 2007;13:6009.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Cho YS, Choi MG, Jeong JJ, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol. 2005;100:747–753.CrossRefPubMed Cho YS, Choi MG, Jeong JJ, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol. 2005;100:747–753.CrossRefPubMed
14.
Zurück zum Zitat Chen M, Xiong L, Chen H, Xu A, He L, Hu P. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: a population-based study in South China. Scand J Gastroenterol. 2005;40:759–767.CrossRefPubMed Chen M, Xiong L, Chen H, Xu A, He L, Hu P. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: a population-based study in South China. Scand J Gastroenterol. 2005;40:759–767.CrossRefPubMed
15.
Zurück zum Zitat Kubota E, Tanida S, Sasaki M, et al. Contribution of Helicobacter pylori infection and obesity on heartburn in a Japanese population. J Clin Biochem Nurt. 2006;39:168–173.CrossRef Kubota E, Tanida S, Sasaki M, et al. Contribution of Helicobacter pylori infection and obesity on heartburn in a Japanese population. J Clin Biochem Nurt. 2006;39:168–173.CrossRef
16.
Zurück zum Zitat Hirakawa K, Adachi K, Amono K, et al. Prevalence of non-ulcer dyspepsia in the Japanese population. J Gastroenterol Hepatol. 1999;14:1083–1087.CrossRefPubMed Hirakawa K, Adachi K, Amono K, et al. Prevalence of non-ulcer dyspepsia in the Japanese population. J Gastroenterol Hepatol. 1999;14:1083–1087.CrossRefPubMed
17.
Zurück zum Zitat Watanabe T, Urita Y, Sugimoto M, Miki K. Gastro-esophageal reflux disease symptoms are more common in general practice in Japan. World J Gastroenterol. 2007;13:4219–4223.CrossRefPubMedPubMedCentral Watanabe T, Urita Y, Sugimoto M, Miki K. Gastro-esophageal reflux disease symptoms are more common in general practice in Japan. World J Gastroenterol. 2007;13:4219–4223.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Fujiwara Y, Higuchi K, Watanabe Y, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol. 2005;20:26–29.CrossRefPubMed Fujiwara Y, Higuchi K, Watanabe Y, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol. 2005;20:26–29.CrossRefPubMed
19.
Zurück zum Zitat Watanabe Y, Fujiwara Y, Shiba M, et al. Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol. 2003;38:807–811.CrossRefPubMed Watanabe Y, Fujiwara Y, Shiba M, et al. Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol. 2003;38:807–811.CrossRefPubMed
20.
Zurück zum Zitat Sakaguchi M, Oka H, Hashimoto T, et al. Obesity as a risk factor for GERD in Japan. J Gastroenterol. 2008;43:57–62.CrossRefPubMed Sakaguchi M, Oka H, Hashimoto T, et al. Obesity as a risk factor for GERD in Japan. J Gastroenterol. 2008;43:57–62.CrossRefPubMed
21.
Zurück zum Zitat Fujisawa T, Kumagai T, Akamatsu T, Kiyosawa K, Matsunaga Y. Changes in seroepidemiological pattern of Helicobacter Pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroeneterol. 1999;94:2094–2099.CrossRef Fujisawa T, Kumagai T, Akamatsu T, Kiyosawa K, Matsunaga Y. Changes in seroepidemiological pattern of Helicobacter Pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroeneterol. 1999;94:2094–2099.CrossRef
22.
Zurück zum Zitat Cremonini F, Di Caro S, Delgado-Aros S, et al. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Phamacol Ther. 2003;18:279–289.CrossRef Cremonini F, Di Caro S, Delgado-Aros S, et al. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Phamacol Ther. 2003;18:279–289.CrossRef
23.
Zurück zum Zitat Haruma K, Kamada T, Kawaguchi H, et al. Effect of age and Helicobacter pylori-infection on gastric acid secretion. J Gastroenterol Hepatol. 2000;15:277–283.CrossRefPubMed Haruma K, Kamada T, Kawaguchi H, et al. Effect of age and Helicobacter pylori-infection on gastric acid secretion. J Gastroenterol Hepatol. 2000;15:277–283.CrossRefPubMed
24.
Zurück zum Zitat Iwakiri K, Kobayashi M, Kotoyori M, Yamasa H, Sugiura T, Nakagawa Y. Relationship between postprandial esophageal acid exposure and meal volume and fat content. Dig Dis Sci. 1996;41:926–930.CrossRefPubMed Iwakiri K, Kobayashi M, Kotoyori M, Yamasa H, Sugiura T, Nakagawa Y. Relationship between postprandial esophageal acid exposure and meal volume and fat content. Dig Dis Sci. 1996;41:926–930.CrossRefPubMed
25.
Zurück zum Zitat Koch KL, Hasler WL, Yates KP, et al. Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes. Neurogastroenterol Motil. 2016;28:1001–1015.CrossRefPubMed Koch KL, Hasler WL, Yates KP, et al. Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes. Neurogastroenterol Motil. 2016;28:1001–1015.CrossRefPubMed
26.
Zurück zum Zitat Kinekawa F, Kubo F, Matsuda K, et al. In the questionnaire for the assessment of gastroesophageal reflux useful for diabetic patients? Scand J Gastroenterol. 2005;40:1017–1020.CrossRefPubMed Kinekawa F, Kubo F, Matsuda K, et al. In the questionnaire for the assessment of gastroesophageal reflux useful for diabetic patients? Scand J Gastroenterol. 2005;40:1017–1020.CrossRefPubMed
27.
Zurück zum Zitat Danjo A, Yamaguchi K, Fujimoto K, et al. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres. J Gastroenterol Hepatol. 2009;24:633–638.CrossRefPubMed Danjo A, Yamaguchi K, Fujimoto K, et al. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres. J Gastroenterol Hepatol. 2009;24:633–638.CrossRefPubMed
28.
Zurück zum Zitat Nonaka T, Kessoku T, Ogawa Y, et al. Comparative study of 2 different questionnaires in Japanese patients: the quality of life and utility evaluation survey technology questionnaire (QUEST) versus the frequency scale for the symptoms of gastroesophageal reflux disease questionnaire (FFSG). J Neurogastroenterol Motil. 2013;19:54–60.CrossRefPubMedPubMedCentral Nonaka T, Kessoku T, Ogawa Y, et al. Comparative study of 2 different questionnaires in Japanese patients: the quality of life and utility evaluation survey technology questionnaire (QUEST) versus the frequency scale for the symptoms of gastroesophageal reflux disease questionnaire (FFSG). J Neurogastroenterol Motil. 2013;19:54–60.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Fujiwara Y, Arakwawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44:518–534.CrossRefPubMed Fujiwara Y, Arakwawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44:518–534.CrossRefPubMed
Metadaten
Titel
Age and Prevalence of Esophageal Reflux Disease in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study
verfasst von
Yoshio Ikeda
Shinya Furukawa
Takenori Sakai
Tetsuji Niiya
Hiroaki Miyaoka
Teruki Miyake
Shin Yamamoto
Hidenori Senba
Yasunori Yamamoto
Eiji Arimitsu
Sen Yagi
Hiroki Utsunomiya
Keiko Tanaka
Eiji Takeshita
Bunzo Matsuura
Yoshihiro Miyake
Yoichi Hiasa
Publikationsdatum
22.09.2016
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 12/2016
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4311-2

Weitere Artikel der Ausgabe 12/2016

Digestive Diseases and Sciences 12/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.